James A. Brink, MD, Radiologist-in-Chief at Massachusetts General Hospital released the following statement on March, 19, 2015:
I am pleased to announce the appointment of Pari Pandharipande, MD, MPH as Director of the MGH Institute for Technology Assessment, succeeding G. Scott Gazelle, MD, MPH, PhD in this role.
ITA Director, Scott Gazelle, MD, PhD, was inducted into the Council of Distinguished Investigators of the Academy of Radiology Research at the 2014 RSNA Annual Meeting. Dr. Gazelle is one of 7 members of the MGH Department of Radiology to be honored in 2014, along with an additional 39 recipients.
To read the entire article, visit Academy of Radiology Research
February 6, 2014
A key challenge to using CTCs is their rarity, according to invited discussant Rebecca A. Miksad of Harvard Medical School and the Beth Israel Deaconess Medical Center, both in Boston.
"In the data presented, the difference between cancer and no cancer is one CTC; similarly, the difference between metastatic and locoregional cancer is one CTC. Because CTCs are detected only in whole numbers, these close cutoffs raise questions about the accuracy, reliability, and reproducibility; in other words, will the same result be found in repeated analysis of the same sample and in different samples from the same patient," she commented.